Skip Nav Destination
Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Epidemiologic study on survival of chronic myeloid leukemia and Ph+ acute lymphoblastic leukemia patients with BCR-ABL T315I mutation
Issue Archive
December 17 2009
Table of Contents
INSIDE BLOOD
PERSPECTIVES
HOW I TREAT
CLINICAL TRIALS AND OBSERVATIONS
Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Clinical Trials & Observations
Nicolaus Kröger,Ernst Holler,Guido Kobbe,Martin Bornhäuser,Rainer Schwerdtfeger,Herrad Baurmann,Arnon Nagler,Wolfgang Bethge,Matthias Stelljes,Lutz Uharek,Hannes Wandt,Andreas Burchert,Paolo Corradini,Jörg Schubert,Martin Kaufmann,Peter Dreger,Gerald G. Wulf,Hermann Einsele,Tatjana Zabelina,Hans Michael Kvasnicka,Jürgen Thiele,Ronald Brand,Axel R. Zander,Dietger Niederwieser,Theo M. de Witte
Epidemiologic study on survival of chronic myeloid leukemia and Ph+ acute lymphoblastic leukemia patients with BCR-ABL T315I mutation
Clinical Trials & Observations
Franck E. Nicolini,Michael J. Mauro,Giovanni Martinelli,Dong-Wook Kim,Simona Soverini,Martin C. Müller,Andreas Hochhaus,Jorge Cortes,Charles Chuah,Inge H. Dufva,Jane F. Apperley,Fumiharu Yagasaki,Jay D. Pearson,Senaka Peter,Cesar Sanz Rodriguez,Claude Preudhomme,Francis Giles,John M. Goldman,Wei Zhou
HEMATOPOIESIS AND STEM CELLS
IMMUNOBIOLOGY
LYMPHOID NEOPLASIA
Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage
Jitka Malcikova,Jana Smardova,Ludmila Rocnova,Boris Tichy,Petr Kuglik,Vladimira Vranova,Sona Cejkova,Miluse Svitakova,Hana Skuhrova Francova,Yvona Brychtova,Michael Doubek,Martin Brejcha,Martin Klabusay,Jiri Mayer,Sarka Pospisilova,Martin Trbusek
Depletion of the C3 component of complement enhances the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal antibody therapy in an in vivo model
Siao-Yi Wang,Suresh Veeramani,Emilian Racila,Jeffrey Cagley,David C. Fritzinger,Carl-Wilhelm Vogel,William St John,George J. Weiner
MYELOID NEOPLASIA
Identification of proapoptotic Bim as a tumor suppressor in neoplastic mast cells: role of KIT D816V and effects of various targeted drugs
Karl J. Aichberger,Karoline V. Gleixner,Irina Mirkina,Sabine Cerny-Reiterer,Barbara Peter,Veronika Ferenc,Michael Kneidinger,Christian Baumgartner,Matthias Mayerhofer,Alexander Gruze,Winfried F. Pickl,Christian Sillaber,Peter Valent
AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations
Jih-Luh Tang,Hsin-An Hou,Chien-Yuan Chen,Chieh-Yu Liu,Wen-Chien Chou,Mei-Hsuan Tseng,Chi-Fei Huang,Fen-Yu Lee,Ming-Chih Liu,Ming Yao,Shang-Yi Huang,Bor-Sheng Ko,Szu-Chun Hsu,Shang-Ju Wu,Woei Tsay,Yao-Chang Chen,Liang-In Lin,Hwei-Fang Tien
PLATELETS AND THROMBOPOIESIS
THROMBOSIS AND HEMOSTASIS
TRANSPLANTATION
VASCULAR BIOLOGY
CORRESPONDENCE
-
Cover Image
Cover Image
Representative picture of bone marrow fibrosis regression in a patient with primary myelofibrosis (grade 3) at day 100 after dose-reduced conditioning followed by allogeneic stem cell transplantation (staining: Gomori silver impregnation). See the article by Kröger et al on page 5264.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals